Credit: CC0 Public Domain People of color and those who experience social vulnerability are more …
Credit: Unsplash/CC0 Public Domain Health insurance companies often deny coverage for new medications that treat …
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist …
Biomimetic artificial islet model for glycemic control. Credit: Prof. Ling Li from Southeast University and …
CamAPS FX. Credit: CamDiab An artificial pancreas developed by researchers at the University of Cambridge …
Credit: Unsplash/CC0 Public Domain In a paper published in Science Translational Medicine, researchers from City …
Graphical abstract. Credit: iScience (2024). DOI: 10.1016/j.isci.2024.109881 In new research, investigators at Massachusetts General Hospital …
Credit: Pixabay/CC0 Public Domain Research led by scientists from the Universities of Oxford and Edinburgh …
Credit: Unsplash/CC0 Public Domain An Australian-first study by the Registry of Senior Australians (ROSA) investigating …
Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed …
Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular …
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor …